drugset
drugset / Trial / NCT04318847

Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial

NCT04318847 ↗

Phase 4 Unknown 220 enrolled Lizar Aguirre Pascasio
RandomizedParallel-groupOpen-labelTreatment

Summary

This clinical trial is intended to evaluate the efficacy and safety of the administration of ondansetron in children with mild-moderate dehydration. The target population will be children between 4 and 13 years old who present vomiting.

Timeline

Start
2021-10-10
Primary completion
2023-04-10
Completion
2023-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 4 mg —
Subject Ondansetron Other / unclassified 8 mg —

Indications

No indication recorded.